The Hobbit singles are doing what I expected them to do.

The initial release hype has started to wear off, more product is entering the market, and prices on many of the premium cards are coming down.

That's not necessarily bad.

In fact, this is the part of the market I'm most interested in.

But I'm not interested in buying a card simply because it's down 30%, 40%, or 50%.

A falling price doesn't automatically make something a good investment.

What I'm looking for is a card where the price is falling faster than my conviction in the underlying thesis.

That's where the opportunity can start to appear.

So this week, I'm watching five cards.

Orcish Bowmasters is one of the cards I'm watching most closely.

The biggest thing I'm seeing is that the price appears to be starting to level off after the initial decline.

That's important.

I'm not trying to perfectly time the bottom. I want to see evidence that the market is beginning to find a more stable price.

And for me, $150 is the number that gets interesting.

At around $150, I think we'd be getting a reasonable entry on a premium version of a card that already has an established Magic identity beyond The Hobbit.

That's important because the investment thesis isn't entirely dependent on Tolkien collectors.

Bowmasters already has demand as a Magic card.

The Hobbit version adds the collector angle.

If the price reaches $150, I would feel much more comfortable owning it.

I'm not saying $150 is the bottom.

I'm saying $150 is a price I'd be willing to make a deal at.

WATCH

Target Entry: $150

Risk: HIGH

Horizon: 1–3 Years

The Queen of Dale is giving us a different signal.

The card has recently found a floor around $120 and bounced from there.

I think that's worth paying attention to.

A bounce doesn't necessarily mean the decline is over. But it does tell us that there is some demand around that level.

More importantly, it gives us a reference point.

We've seen the market get down toward $120.

So I'm not interested in chasing the card simply because it bounced.

I'd actually like to see it come down again.

Ideally, I'd like to see the Queen of Dale below $100.

At that price, I'd be much more interested in taking a position.

The Tolkien character appeal is still there. The premium Surge Foil treatment is still there. The collector thesis hasn't disappeared.

But I want to pay a price that gives me some room for that thesis to play out.

For now, I'm watching.

WATCH

Target Entry: <$100

Risk: HIGH

Horizon: 1–3 Years

The Arkenstone was on my radar in the first Market Watch, and I'm still watching it.

The interesting part is what's happened to the price.

The Borderless Surge Foil is now around $180 on TCGplayer Low.

That's a meaningful move from where we were previously.

And this is exactly why I don't want to chase cards simply because I like them.

I liked The Arkenstone before.

I still like The Arkenstone.

But my target hasn't changed.

I'm still looking for around $150.

The investment thesis remains attractive to me.

It's one of the most recognizable objects from Tolkien's story, it's a premium treatment, and the card itself has legitimate Commander utility. TCGplayer has also highlighted The Arkenstone among the best-selling cards from The Hobbit, citing its Commander utility and premium variant.

Wizards also confirms that Surge Foil Dragon Hoard treatments are exclusive to Collector Boosters, which supports the premium-treatment scarcity angle we're interested in.

But at $180, I'm still waiting.

$150 is where I want to start taking this seriously.

WATCH

Target Entry: $150

Risk: MEDIUM/HIGH

Horizon: 1–3 Years

Orcrist is probably the most speculative card on this list.

And that's exactly why I'm watching it.

The price has already come down considerably from the levels we were looking at earlier.

But I don't think the question is simply:

The better question is:

For me, that number is somewhere around $60–$75.

Orcrist has several things going for it.

It's an iconic Tolkien weapon.

It's a premium treatment.

And unlike a purely decorative collectible, the card has legitimate Commander utility.

But the collector thesis isn't enough for me at the current price.

I'd rather wait.

If the market gives us Orcrist around $60–$75, I'll take a much harder look.

WATCH

Target Entry: $60–$75

Risk: MEDIUM

Horizon: 1–3 Years

Thanos is the one card on this list that isn't from The Hobbit.

And there's a reason I'm bringing it back.

I watched this card in Market Watch #001, and the thesis hasn't changed.

The price is still falling.

That's actually useful information.

I'm not going to move my target simply because the card hasn't reached it yet.

I still like around $130.

The appeal here is primarily the character and the artwork.

I'm less interested in Thanos as a Magic card than I am in the long-term collectible appeal of a premium Thanos card.

That makes this a higher-risk thesis.

But if the price continues to fall toward $130, the equation starts looking more interesting.

For now, I'm comfortable waiting.

Sometimes the right move is simply not buying yet.

WATCH

Target Entry: ~$130

Risk: HIGH

Horizon: 1–3 Years

Five cards.

Five different reasons to watch them.

POSITION: WATCH
RISK: HIGH
TARGET ENTRY: $150

POSITION: WATCH
RISK: HIGH
TARGET ENTRY: $100

POSITION: WATCH
RISK: MEDIUM/HIGH
TARGET ENTRY: $150

POSITION: WATCH
RISK: MEDIUM
TARGET ENTRY: $60-$75

POSITION: WATCH
RISK: HIGH
TARGET ENTRY: ~$130

Target entries are Pack Portfolio's current targets, not predictions of where prices will trade.

There's a temptation in a falling market to think:

I'm trying to avoid that.

The Hobbit is still a very new set. It released on August 14, 2026, and Collector Boosters contain many of the premium treatments we're watching, including Surge Foils and other exclusive treatments.

That means we're still learning where these cards ultimately settle.

More product can enter the market.

Collectors can change their minds.

Players can move on to the next set.

Or demand can prove stronger than expected.

I don't need to predict which one happens.

I just need to know what price would make me comfortable taking the risk.

That's why the targets matter.

For me, the answer isn't simply a specific number.

I want to see two things happen together:

The price becomes attractive.

And:

The underlying thesis remains intact.

If Orcish Bowmasters reaches $150 but demand completely disappears, that's not necessarily a bargain.

If The Arkenstone reaches $150 while collector and Commander demand remain healthy, that's a much more interesting situation.

Price matters.

But price relative to the thesis matters more.

I'm watching these cards because I think the market is finally getting interesting.

Not because I think every card that's falling is a bargain.

The Hobbit had a huge launch, and we're now getting our first real look at what these cards are worth after the initial excitement fades.

Some will continue falling.

Some will stabilize.

And a few could eventually reach prices where I want to own them.

For now, I'm waiting for my numbers.

$150 for Orcish Bowmasters.

Below $100 for Queen of Dale.

$150 for The Arkenstone.

$60–$75 for Orcrist.

Around $130 for Thanos.

I'm not trying to catch the exact bottom.

I'm trying to buy when the price gives me enough room for the thesis to be wrong and still make sense.

That's what I'm watching.

I bought one at MSRP. Here's what I'd pay for a second.

Read the Full Article →

The broader market split between singles and sealed, and seeing what direction the market is heading.

Read Weekly Pack #002 →

A deeper look at Mox Amber — Dwarvish Borderless Foil, including my own $650 entry and why I'm willing to hold it for the long term.

Read Golden Pack #001 →

Pack Portfolio is an independent research publication focused on trading cards as collectible assets. Our opinions are our own and are not financial advice. Prices change quickly, and readers should conduct their own research before buying or selling any collectible.